Cord Blood Stem Cells Market

The global Cord Blood Stem Cells market was valued at USD 1535 Million in 2020 and is projected to reach USD 4756 Million by 2028, growing at a CAGR of 5.3% from 2021 to 2028.

After a baby is born, cord blood is left in the umbilical cord and placenta. It is relatively easy to collect, with no risk to the mother or baby. It contains hematopoietic (blood) stem cells: rare cells normally found in the bone marrow.

This report provides an analysis of the Cord Blood Stem Cells market for the historic period of 2016–2019 and forecasts for 2021–2028 while 2020 is considered as a base year for estimations. The report includes exhaustive analysis of segments, regions and countries comprising of market size and estimations in terms of revenue for the years 2016–2028. There regional section of the report is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, the report also covers exhaustive information on growth factors/drivers, restraints, opportunities, regulatory landscape and technology roadmap among others. Moreover, the report also includes exhaustive SWOT analysis, PEST analysis, value chain analysis, and Porter’s five forces analysis on Cord Blood Stem Cells market. This data is likely to help the industry stakeholders and stimulate the decision-making process.

The COVID-19 outbreak has affected various industries worldwide. The Cord Blood Stem Cells market is no exception. Governments across the world took severe actions like border seals, lockdown, and implementing strict social distancing measures, in order to stop swift spread of COVID-19. These actions led to severe impact on the global economy. Industrialist across the globe were forced to halt their production, leading to supply chain disruptions and impairing of various industries. However, it is expected that reopening of trade activities, the market will witness steady growth in demand in the coming years. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends for all the regions and countries.

The report provides a completely separate chapter for COVID-19 Impact Analysis. This chapter includes:

o   Impact Assessment of COVID-19 Pandemic

o   Pre & Post COVID-19 Market Size

o   Qualitative analysis on the short term & long-term impact of COVID-19 on the market

o   The analysis provides foremost strategies adopted by competitors to minimize the impact of the pandemic on their business activities and scope for future developments.

Key driver for the market is that transplants of hematopoietic stem cells (HSCs) from cord blood can be used to treat several different blood diseases, such as leukemia. 

Stem cells can be used in treatments for many different types of diseases. One of the main places young stem cells are found is in cord blood, which can be stored at birth and saved for future use if needed. 

The increase in prices of advanced surgeries is expected to hamper the growth of the market in forecast period.

The report delivers an acute breakdown of the market based on various segments such as Type, Application, , and region. The report includes market size and forecast for each segment by region/country for the years 2016–2028. Moreover, it also covers a thorough analysis of growth factors and opportunities impacting segmental growth.

On the basis of Type, the market is divided into Allogeneic Stem Cell, Autologous Stem Cell. Allogeneic Stem Cell dominated the global Cord Blood Stem Cells market in 2020 and is projected to witness the same trend during the forecast period.

Based on Application, the market is segmented into Autoimmune Diseases, Immunodeficiencies, Malignancies,Caners, Solid Tumors, Others. Autoimmune Diseases accounted for the highest market share and is expected to grow at a significant CAGR from 2021 to 2028. 

Based on the geography, the global Cord Blood Stem Cells market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. Moreover, the regional sections if further bifurcated into key country level markets for better understanding of the market.

The report covers detailed analysis on drivers, business opportunities, regulatory norms, supplier concertation and such other factors impacting regional growth. Moreover, it also covers market estimations and forecast for each segment for each region for the years 2016–2028. 

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of MEA

The global Cord Blood Stem Cells market report provides an exhaustive competitive landscape to give a comprehensive synopsis of the global market. Major players in the Cord Blood Stem Cells market are BioCell Pty. Ltd., Kaneka Corporation, DomaniCell LLC, Future Health Technologies, Eticur, Advanced Cell Technology Inc., Banco De Celulas Madre, J.P. McCarthy Cord Stem Cell Bank, CyGenics Ltd, AlphaCord..  This section of the report provides in depth analysis on key market players based on various parameters such as business overview, portfolio analysis, business strategies, financial performance, geographical presence, and recent developments among others. It will also include information on key strategies adopted by major market players. 

• The global Cord Blood Stem Cells market was valued at USD 1535 Million in 2020
• The global Cord Blood Stem Cells Market is projected to reach USD 4756 Million by 2028
• North America held the highest share of the Cord Blood Stem Cells market in 2020
• Some of the major companies operating in the Cord Blood Stem Cells market are BioCell Pty. Ltd., Kaneka Corporation, DomaniCell LLC, Future Health Technologies, Eticur, Advanced Cell Technology Inc., Banco De Celulas Madre, J.P. McCarthy Cord Stem Cell Bank, CyGenics Ltd, AlphaCord.